We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.25B
AUM Growth
-$25.4M
Cap. Flow
+$12.2M
Cap. Flow %
0.29%
Top 10 Hldgs %
16.34%
Holding
741
New
37
Increased
257
Reduced
342
Closed
37

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$29.8M
2
META icon
Meta Platforms (Facebook)
META
+$12.5M
3
AERI
Aerie Pharmaceuticals
AERI
+$10.4M
4
CME icon
CME Group
CME
+$10.1M
5
TVRD
Tvardi Therapeutics
TVRD
+$8.03M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$38.8M
2
FNSR
Finisar Corp
FNSR
+$16.2M
3
LRCX icon
Lam Research
LRCX
+$11.3M
4
MRK icon
Merck
MRK
+$9.45M
5
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$7.94M

Sector Composition

Rank Sector Weight
1 Technology 21.59%
2 Communication Services 12.14%
3 Industrials 11.8%
4 Healthcare 11.37%
5 Financials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
76
RTX Corp
RTX
$290B
$14.9M 0.35%
173,945
+1,558
+0.9% +$129K
PTLA
77
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$14.9M 0.35%
554,479
+139,400
+34% +$3.91M
LSXMA
78
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$14.7M 0.35%
489,429
-13,936
-3% -$407K
TOTL icon
79
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.1B
$14.5M 0.34%
294,840
+605
+0.2% +$29.7K
AMGN icon
80
Amgen
AMGN
$209B
$14.4M 0.34%
74,442
+3,237
+5% +$621K
GILD icon
81
Gilead Sciences
GILD
$165B
$14.3M 0.34%
225,358
-1,881
-0.8% -$123K
CVS icon
82
CVS Health
CVS
$135B
$13.9M 0.33%
221,162
+24,908
+13% +$1.48M
NEE icon
83
NextEra Energy
NEE
$185B
$13.7M 0.32%
235,324
-4,080
-2% -$221K
DAL icon
84
Delta Air Lines
DAL
$56.7B
$13.6M 0.32%
236,762
-4,680
-2% -$277K
LASR icon
85
nLIGHT
LASR
$3.33B
$13.6M 0.32%
870,549
+84,905
+11% +$1.32M
LMT icon
86
Lockheed Martin
LMT
$131B
$13.6M 0.32%
34,752
+1,390
+4% +$523K
DIS icon
87
Walt Disney
DIS
$171B
$13.5M 0.32%
103,343
+423
+0.4% +$58.5K
VV icon
88
Vanguard Morningstar Large-Cap ETF
VV
$51.2B
$13M 0.31%
95,657
-1,364
-1% -$185K
BND icon
89
Vanguard Total Bond Market
BND
$158B
$13M 0.31%
153,609
+6,829
+5% +$572K
ICPT
90
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12.7M 0.3%
191,188
+61,373
+47% +$4.12M
USMV icon
91
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
$12.4M 0.29%
192,813
+105,716
+121% +$6.7M
UNH icon
92
UnitedHealth
UNH
$382B
$12.4M 0.29%
56,846
+1,341
+2% +$324K
AEIS icon
93
Advanced Energy
AEIS
$10.1B
$12.3M 0.29%
214,848
-13,105
-6% -$708K
KYNB
94
Kyntra Bio
KYNB
$27.4M
$12.3M 0.29%
13,300
-515
-4% -$566K
BMY icon
95
Bristol-Myers Squibb
BMY
$129B
$12.1M 0.29%
239,079
+4,355
+2% +$205K
PARA
96
DELISTED
Paramount Global Class B
PARA
$12.1M 0.29%
300,246
-995
-0.3% -$46.6K
HP icon
97
Helmerich & Payne
HP
$3.34B
$12.1M 0.29%
301,950
-18,127
-6% -$800K
AXP icon
98
American Express
AXP
$224B
$12M 0.28%
101,740
+4,034
+4% +$495K
IBM icon
99
IBM
IBM
$213B
$11.9M 0.28%
85,701
+13,502
+19% +$1.82M
MYGN icon
100
Myriad Genetics
MYGN
$476M
$11.8M 0.28%
412,581
-28,157
-6% -$820K
2 3
4
5 6

Similar funds

EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Pinnacle Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Pinnacle Associates held 741 positions worth $4.25B, down 0.6% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pinnacle Associates's Q3 2019 filing shows 37 new, 257 increased, 342 reduced and 37 closed positions. Its largest new stake was Aerie Pharmaceuticals: 454,750 shares worth $8.74M. The largest sale was Array Biopharma Inc, an estimated $38.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Communication Services and Industrials.

  • Pinnacle Associates's largest Q3 2019 buy was Aerie Pharmaceuticals: 454,750 shares worth $8.74M.
  • Pinnacle Associates added most to Apple in Q3 2019, an estimated $29.8M increase.
  • Pinnacle Associates's biggest Q3 2019 reduction was Lam Research, cutting an estimated $11.3M.
  • Pinnacle Associates fully exited Array Biopharma Inc in Q3 2019, selling an estimated $38.8M.
  • Pinnacle Associates's ten largest holdings make up 16% of its $4.25B portfolio in Q3 2019.
  • Pinnacle Associates opened 37 new positions and closed 37 in Q3 2019.
  • Pinnacle Associates's portfolio value fell 0.6% quarter-over-quarter to $4.25B.

Based on Pinnacle Associates's 13F filing for Q3 2019, filed 8 Nov 2019.